Literature DB >> 11668665

Acute panic inventory symptoms during CO(2) inhalation and room-air hyperventilation among panic disorder patients and normal controls.

R R Goetz1, D F Klein, L A Papp, J M Martinez, J M Gorman.   

Abstract

There is scant literature on anxiety symptoms induced during respiratory challenges developed to induce panic symptoms and attacks. Here we report on the prevalence of Acute Panic Inventory (API) symptoms during three consecutive respiratory challenges to patients with panic disorder (PD) and normal controls (NC). The challenges performed using a closed canopy system included voluntary room air hyperventilation (RAH), inhalation of 5% CO(2), and 7% CO(2)-enriched air. The PD patients were 41 men and 53 women whose mean age was 33.4 (SD = 8.55). The normal comparison group consisted of 35 men and 27 women with a mean age of 31.3 (SD = 9.21). The diagnosis of panic disorder was made using the Structured Clinical Interview for DSM-III-R. All potential normal controls underwent structured clinical interview using the Schedule for Affective Disorders and Schizophrenia-Lifetime Version Modified for the Study of Anxiety Disorders (SADS-LA), and must have been free of a lifetime history of anxiety disorders, affective disorders, substance use disorders, and schizophrenia. All participants also had a complete medical evaluation and were in good health. The experiment consisted of seven experimental epochs: three baseline/recovery periods each followed by a respiratory challenge, and then a final recovery epoch. The API was administered at the end of each epoch. Clinical staff trained and experienced in rating panic attacks rated participants' response during each challenge as panic or no panic. Three groups were defined for analysis: PD patients who panicked, PD patients who did not panic, and NC who did not panic. Staff ratings indicated that the 7% CO(2) challenge was the most panicogenic, followed by the 5% CO(2), and the RAH challenges. Conventional statistics (analysis of variance and partial correlations) indicated that many baseline symptoms as well as symptom increments differed across groups, and were associated with the outcome of panic/no panic during each challenge. However, logistic regression analysis indicated that only a few symptoms independently predicted the panic/no panic outcome because many symptoms were redundant. The symptom cluster of fear in general, dizziness, difficulties with concentrating, and doing one's job predicted panic to RAH. The cluster of fear in general, confusion, dyspnea, and twitching/trembling predicted the response to 5% CO(2). Finally, fear in general, confusion, twitching/ trembling and dizziness predicted the response to 7% CO(2). While univariate analyses indicated that many symptoms distinguished between panic and no panic outcome, logistic regression revealed that group differences were subsumed under a few prominent symptoms, namely, fear in general, confusion, dizziness, twitching/trembling, and dyspnea. The results are discussed in the context of patient (having a diagnosis of PD) and panic effects (rated as panicking to a challenge). Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668665     DOI: 10.1002/da.1054

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  10 in total

Review 1.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

2.  Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia.

Authors:  Philip L Johnson; Brian C Samuels; Stephanie D Fitz; Stafford L Lightman; Christopher A Lowry; Anantha Shekhar
Journal:  Neuropsychopharmacology       Date:  2012-03-28       Impact factor: 7.853

Review 3.  An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus.

Authors:  Philip L Johnson; Anantha Shekhar
Journal:  Physiol Behav       Date:  2012-03-26

4.  Changes in central sodium and not osmolarity or lactate induce panic-like responses in a model of panic disorder.

Authors:  Andre I Molosh; Philip L Johnson; Stephanie D Fitz; Joseph A Dimicco; James P Herman; Anantha Shekhar
Journal:  Neuropsychopharmacology       Date:  2010-02-03       Impact factor: 7.853

Review 5.  Role of chemoreceptors in mediating dyspnea.

Authors:  Gordon F Buchanan; George B Richerson
Journal:  Respir Physiol Neurobiol       Date:  2008-12-11       Impact factor: 1.931

6.  Evaluation of Low versus High Volume per Minute Displacement CO₂ Methods of Euthanasia in the Induction and Duration of Panic-Associated Behavior and Physiology.

Authors:  Debra L Hickman; Stephanie D Fitz; Cristian S Bernabe; Izabela F Caliman; Melissa M Haulcomb; Lauren M Federici; Anantha Shekhar; Philip L Johnson
Journal:  Animals (Basel)       Date:  2016-08-02       Impact factor: 2.752

7.  Does physiological arousal lead to increased catastrophic misinterpretation? An experiment based on the concept of a fear memory.

Authors:  Barnabas Ohst; Brunna Tuschen-Caffier
Journal:  BMC Psychol       Date:  2020-02-13

8.  Humanely Ending the Life of Animals: Research Priorities to Identify Alternatives to Carbon Dioxide.

Authors:  Aline R Steiner; Shannon Axiak Flammer; Ngaio J Beausoleil; Charlotte Berg; Regula Bettschart-Wolfensberger; Rebeca García Pinillos; Huw D W Golledge; Michael Marahrens; Robert Meyer; Tobias Schnitzer; Michael J Toscano; Patricia V Turner; Daniel M Weary; Thomas C Gent
Journal:  Animals (Basel)       Date:  2019-11-02       Impact factor: 2.752

9.  Different patterns of respiration in rat lines selectively bred for high or low anxiety.

Authors:  Luca Carnevali; Andrea Sgoifo; Mimosa Trombini; Rainer Landgraf; Inga D Neumann; Eugene Nalivaiko
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

Review 10.  Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior.

Authors:  James H Fox; Christopher A Lowry
Journal:  Front Neurosci       Date:  2013-09-20       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.